Skip to content

Impact of Time-Restricted Eating plus Nutritional Intervention on Liver Fat Content in Patients with MASLD and Overweight or Obesity: A Randomized Controlled Trial

Impact of Time-Restricted Eating plus Nutritional Intervention on Liver Fat Content in Patients with MASLD and Overweight or Obesity: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112340
Enrollment
Unknown
Registered
2025-11-12
Start date
2025-11-12
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MASLD

Interventions

Nutrition Intervention Group:Provide nutritional meal packs
Time-restricted eating+Nutrition Intervention Group:Nutrition Intervention and time-restricted eating

Sponsors

Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age 20-60 years; (2) BMI between 24 kg/m² and 40 kg/m²; (3) Diagnosis of fatty liver (confirmed by MRI-PDFF with hepatic fat fraction =5%);

Exclusion criteria

Exclusion criteria: (1) Concurrent with other chronic liver diseases (e.g., hepatitis B or C, autoimmune hepatitis, chronic cholestatic liver disease) or use of medications with potential hepatotoxicity (such as tamoxifen, methotrexate, valproic acid, systemic corticosteroids); (2) Presence of severe cardiac, cerebral, or renal diseases, or liver cirrhosis; (3) History of eating disorders or significant recent weight fluctuations; (4) Currently pregnant, breastfeeding, or planning to become pregnant within the next six months; (5) Currently participating in a weight loss or weight management program; (6) Suffering from claustrophobia or having implanted medical devices (e.g., cardiac pacemakers, metallic implants, or devices with ferromagnetic properties) that preclude magnetic resonance imaging (MRI) examination.

Design outcomes

Primary

MeasureTime frame
Hepatic Fat Content;

Secondary

MeasureTime frame
Abdominal MRI;weight;BMI;Waist circumference;Hip circumference;body composition;Blood pressure;Pulse rate;Blood glucose;Blood lipids;Liver function;Metagenomics;Metabolomics;Proteomics;Transient Elastography;Transcriptome;

Countries

China

Contacts

Public ContactShuang, Rong

Wuhan University

rongshuang@ustc.edu.cn+86 185 7172 7264

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026